Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 25.58 percent increase over losses of $(0.43) per share from the same period last year.
Sana Biotechnology (NASDAQ:SANA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 25.58 percent increase over losses of $(0.43) per share from the same period last year.
Comments